Latest Articles, News & Analysis on aussie healthcare | Livewire

Equities

This company knocked back a $20 billion takeover offer. Was it worth it?

Rumours of a private equity takeover were the story of 2022 for this company. What will 2023 bring?

Hans Lee

Hans Lee

Livewire Markets

most popular

Education

An investment that will pay dividends for decades, if not centuries

Livewire Exclusive,

Livewire Markets

Equities

Rare earths in abundance for RareX as resource soars 500%

Barry FitzGerald,

Independent Journalist

Funds

6 ASX-listed products for the risk-loving and risk-averse investor

Buy Hold Sell,

Livewire Markets

Equities

Do CSL and Mineral Resources still deserve “market darling” status?

David Thornton,

Livewire Markets

view all

Sponsored